CA
1
-9
MO
56
5
BAX
53
3
V
58
-14
RIG
35
-3
ED
49
4
MMM
69
3
AAPL
46
-2
PNW
62
5
GOOG
69
14
UA
48
-8
HUM
31
3
FRT
60
2
KEY
57
-10
ZBH
51
-2
MUR
35
-4
EA
52
2
UNM
62
3
NI
75
3
PSA
53
3
CA
1
-9
MO
56
5
BAX
53
3
V
58
-14
RIG
35
-3
ED
49
4
MMM
69
3
AAPL
46
-2
PNW
62
5
GOOG
69
14
UA
48
-8
HUM
31
3
FRT
60
2
KEY
57
-10
ZBH
51
-2
MUR
35
-4
EA
52
2
UNM
62
3
NI
75
3
PSA
53
3
Financhill
Back

United Utilities Group PLC Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
56

UUGRY
United Utilities Group PLC

Last Price:
$29.64
Seasonality Move:
-0.61%
Buy
57

HALO
Halozyme Therapeutics

Last Price:
$52.01
Seasonality Move:
2.59%
Buy
56
United Utilities Group PLC (UUGRY) is a Buy

Is United Utilities Group PLC a Buy, Sell or Hold?

  • The current United Utilities Group PLC [UUGRY] share price is $29.64. The Score for UUGRY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • UUGRY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $52.02. The Score for HALO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UUGRY Stock Price Chart

What is United Utilities Group PLC's stock price today?

  • The United Utilities Group PLC share price today is $29.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UUGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $52.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

UUGRY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.37 Buy
Relative Strength Index (14 RSI): 58 Buy
Chaikin Money Flow: 21217 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.7 - 29.92) Buy
Bollinger Bands (100): (24.27 - 28.21) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.93 Sell
Relative Strength Index (14 RSI): 39.77 Sell
Chaikin Money Flow: 2565199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.26 - 64.74) Sell
Bollinger Bands (100): (52.42 - 62.84) Sell

UUGRY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.07 Buy
20-day SMA: 29.43 Buy
50-day SMA: 27.54 Buy
200-day SMA: 26.72 Buy
8-day EMA: 29.15 Buy
20-day EMA: 29.01 Buy
50-day EMA: 27.96 Buy
200-day EMA: 26.78 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.68 Sell
20-day SMA: 59.36 Sell
50-day SMA: 60.81 Sell
200-day SMA: 56.35 Sell
8-day EMA: 55.37 Sell
20-day EMA: 58.4 Sell
50-day EMA: 59.26 Sell
200-day EMA: 55.4 Sell

United Utilities Group PLC Earnings Growth & UUGRY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

United Utilities Group PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):